How does sibutramine work?

被引：44
|
作者：
Lean, MEJ [1 ]
机构：
[1] Univ Glasgow, Dept Human Nutr, Royal Infirm, Glasgow G31 2ER, Lanark, Scotland
来源：
INTERNATIONAL JOURNAL OF OBESITY | 2001年 / 25卷 / Suppl 4期
关键词：
sibutramine; serotonin and noradrenaline reuptake inhibitor (SNRI); energy intake; energy expenditure; weight loss;
D O I：
10.1038/sj.ijo.0801931
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Sibutramine offers three types of benefit in weight management: by enhancing weight loss, by improving weight maintenance and by reducing the comorbidities of obesity. The clinical effects of sibutramine are explained through its known mode of action as a serotonin (5-HT) and noradrenaline reuptake inhibitor (SNRI). This dual mechanism of action results in two synergistic physiological effects-a reduction in energy intake and an increase in energy expenditure, which combine to promote and maintain weight loss.
引用
收藏
页码：S8 / S11
页数：4
相关论文
共 50 条
  • [21] The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females
    KM Walsh
    E Leen
    MEJ Lean
    International Journal of Obesity, 1999, 23 : 1009 - 1015
  • [22] The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females
    Walsh, KM
    Leen, E
    Lean, MEJ
    INTERNATIONAL JOURNAL OF OBESITY, 1999, 23 (10) : 1009 - 1015
  • [23] Proteome changes in rat plasma in response to sibutramine
    Choi, Jung-Won
    Joo, Jeong In
    Kim, Dong Hyun
    Wang, Xia
    Oh, Tae Seok
    Choi, Duk Kwon
    Yun, Jong Won
    PROTEOMICS, 2011, 11 (07) : 1300 - 1312
  • [24] Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: A placebo-controlled trial
    Wadden, TA
    Berkowitz, RI
    Womble, LG
    Sarwer, DB
    Arnold, ME
    Steinberg, CM
    OBESITY RESEARCH, 2000, 8 (06): : 431 - 437
  • [25] NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine
    Erondu, Ngozi
    Addy, Carol
    Lu, Kaifeng
    Mallick, Madhuja
    Musser, Bret
    Gantz, Ira
    Proietto, Joseph
    Astrup, Arne
    Toubro, Soren
    Rissannen, Aila M.
    Tonstad, Serena
    Haynes, William G.
    Gottesdiener, Keith M.
    Kaufman, Keith D.
    Amatruda, John M.
    Heymsfield, Steven B.
    OBESITY, 2007, 15 (08) : 2027 - 2042
  • [26] Comparison of the effects of sibutramine versus sibutramine plus metformin in obese women
    Ramazan Sari
    Esin Eray
    Sabahat Ozdem
    Halide Akbas
    Erkan Coban
    Clinical and Experimental Medicine, 2010, 10 : 179 - 184
  • [27] Sibutramine in clinical practice
    N Finer
    International Journal of Obesity, 2001, 25 : S12 - S15
  • [28] Sibutramine hydrochloride monohydrate
    Oliveira, P. R.
    Stulzer, H. K.
    Bernardi, L. S.
    Borgmann, S. H. M.
    Cardoso, S. G.
    Silva, M. A. S.
    JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2010, 100 (01) : 277 - 282
  • [29] Sibutramine on Cardiovascular Outcome
    Scheen, Andre J.
    DIABETES CARE, 2011, 34 : S114 - S119
  • [30] Withdrawal of sibutramine in Europe
    Williams, Gareth
    BMJ-BRITISH MEDICAL JOURNAL, 2010, 340
12345